Biomarkers and epidemiology
11 – 20 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
- Contribution to journal › Article
-
Mark
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT : a randomized clinical trial with long-term follow-up
- Contribution to journal › Article
-
Mark
Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation
- Contribution to journal › Article
-
Mark
Racial variation in the advanced prostate cancer genome
- Contribution to journal › Article
-
Mark
Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
- Contribution to journal › Scientific review
-
Mark
Identifying prognostic targets in metastatic prostate cancer beyond AR
- Contribution to journal › Article
-
Mark
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
- Contribution to journal › Article
-
Mark
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer : insights from the randomized SweBCG91RT trial
- Contribution to journal › Article
- 2024
-
Mark
Clinical cell-surface targets in metastatic and primary solid cancers
- Contribution to journal › Article
-
Mark
PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
- Contribution to journal › Article
